1-3 of 3
Ferdinand Evangelista
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Anti-TweakR antibodies inhibit tumor growth in vivo through dual mechanisms

Patricia Culp, Yongke Zhang, Johnny Yin, Donghee Choi, Pui Seto, Suzanne Ybarra, David Powers, Marjorie James, Ferdinand Evangelista, Jennifer Grove, Melanie Wong, Robert Dubridge, Vanitha Ramakrishnan
Journal: Cancer Research
Cancer Res (2008) 68 (9_Supplement): 1511.
Published: 01 May 2008
View article
Journal Articles

Validation of TMEFF2 as a therapeutic target in bone metastasized prostate cancer and in in vivo models.

Daniel Afar, Vinay Bhaskar, Eric Ibsen, Danna Breinberg, Marija Drobnjak, Rick Powers, Melanie Wong, Ferdinand Evangelista, Chris O’Hara, Robert Dubridge, Susan Henshall, Robert Sutherland, Howard I. Scher, Carlos Cordon-Cardo, Richard Murray, Vanitha Ramakrishnan, Debbie Law
Journal: Cancer Research
Cancer Res (2004) 64 (7_Supplement): 705–706.
Published: 01 April 2004
View article
Journal Articles

E-Selectin Up-Regulation Allows for Targeted Drug Delivery in Prostate Cancer

Vinay Bhaskar, Debbie A. Law, Eric Ibsen, Danna Breinberg, Kellie M. Cass, Robert B. DuBridge, Ferdinand Evangelista, Susan M. Henshall, Peter Hevezi, Jennifer C. Miller, Melody Pong, Rick Powers, Peter Senter, David Stockett, Robert L. Sutherland, Ursula von Freeden-Jeffry, Dorian Willhite, Richard Murray, Daniel E. H. Afar, Vanitha Ramakrishnan
Journal: Cancer Research
Cancer Res (2003) 63 (19): 6387–6394.
Published: 14 October 2003
View article
PDF